Evidence map›Paper›PMID 35228555›Full record

ReviewNature communications2022

Traditional and sustainable approaches for the construction of C-C bonds by harnessing C-H arylation.

Jagrit Grover, Gaurav Prakash, Nupur Goswami, Debabrata Maiti

Abstract readReview
In one paragraph

Review in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Pd(II)-Catalyzed Strategies for the β-Arylation of α-Amino Acids: An Overview.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. A Photoredox C-H Arene Functionalization toward Substituted Methyls.Journal of the American Chemical Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecules (Basel, Switzerland) · 2025
    Article
  8. The Versatile and StrategicChemical reviews · 2024
    Review
  9. Article
  10. Article
  11. Directing group assistedChemical science · 2023
    Article
  12. Improving the sustainability of the ruthenium-catalysedGreen chemistry : an international journal and green chemistry resource : GC · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jagrit Grover *Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India.
Gaurav Prakash *Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India.
Nupur GoswamiDepartment of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India.
Debabrata MaitiDepartment of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India. dmaiti@chem.iitb.ac.in.ORCID http://orcid.org/0000-0001-8353-1306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biaryl scaffolds are found in natural products and drug molecules and exhibit a wide range of biological activities. In past decade, the transition metal-catalyzed C-H arylation reaction came out as an effective tool for the construction of biaryl motifs. However, traditional transition metal-catalyzed C-H arylation reactions have limitations like harsh reaction conditions, narrow substrate scope, use of additives etc. and therefore encouraged synthetic chemists to look for alternate greener approaches. This review aims to draw a general overview on C-H bond arylation reactions for the formation of C-C bonds with the aid of different methodologies, majorly highlighting on greener and sustainable approaches.

Indexed as

Biological ProductsTransition ElementsCarbonCatalysisBiological ProductsCarbonTransition Elements

Identifiers

PMID35228555
PMCPMC8885660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.